Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monocytes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05637905
What this trial is testing

Monocyte Chemoattractant Protein-1 in Psoriatic Arthritis Patients

Who this might be right for
Psoriatic Arthritis
Assiut University 44
Not applicableLooking for participantsNCT06361641
What this trial is testing

Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes

Who this might be right for
Myeloproliferative NeoplasmPolycythemia VeraEssential Thrombocythemia+1 more
University Hospital, Angers 70
Not applicableLooking for participantsNCT07821190
What this trial is testing

MDW as a Novel Diagnostic Biomarker in LONS Among Preterm Neonates

Who this might be right for
Late Onset Neonatal Sepsis
Tanta University 60
Early research (Phase 1)Study completedNCT00470197
What this trial is testing

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT01356836
What this trial is testing

The Association Between Different Monocyte Subsets and Coronary Collateral Development

Who this might be right for
Coronary Artery DiseaseCoronary Ischemia
Yuksek Ihtisas Hospital 105
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Post-approval studies (Phase 4)Study completedNCT02383355
What this trial is testing

Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation

Who this might be right for
HIV
Radboud University Medical Center 40
Not applicableStudy completedNCT02180009
What this trial is testing

Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis

Who this might be right for
SepsisSevere SepsisSeptic Shock
Chinese PLA General Hospital 1
Not applicableUnknownNCT03842371
What this trial is testing

Metabolism of Branched-chain Amino Acids in Monocyte/Macrophage During Sepsis

Who this might be right for
Sepsis Syndrome
West China Hospital 90
Not applicableUnknownNCT05347836
What this trial is testing

Monocyte Soluble Activation Markers sCD14 and sCD163 in Children With Type 1 Diabetes Mellitus

Who this might be right for
Type1diabetes
Assiut University 90
Not applicableStudy completedNCT00893165
What this trial is testing

Does Moderate Physical Activity in Hemodialysis Patients Reduce Inflammation?

Who this might be right for
End-stage Renal DiseaseHemodialysis
Martin-Luther-Universität Halle-Wittenberg 16
Not applicableStudy completedNCT02545621
What this trial is testing

A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study

Who this might be right for
Acute Respiratory Distress SyndromeMechanical Ventilation
University Hospital, Clermont-Ferrand 20
Testing effectiveness (Phase 2)Study completedNCT00602771
What this trial is testing

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
National Cancer Institute (NCI) 84
Early research (Phase 1)Study completedNCT00268229
What this trial is testing

Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 21
Very early researchUnknownNCT04803929
What this trial is testing

Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

Who this might be right for
AML M4AML M5
Carbiogene Therapeutics Co. Ltd. 25
Not applicableStudy completedNCT03250897
What this trial is testing

Phenotypic Characterization of Alveolar Macrophages 2016 (Caract-Aires-2016)

Who this might be right for
Lung Diseases
Rennes University Hospital 18
Not applicableStudy completedNCT07433127
What this trial is testing

Inflammation Indıces and Mortality in Adult Crush Syndrome

Who this might be right for
Crush SyndromeRhabdomyolysisSystemic Inflammatory Response+1 more
Ataturk University 325
Testing effectiveness (Phase 2)Study completedNCT00305773
What this trial is testing

Vorinostat in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Erythroid Leukemia (M6)Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+15 more
National Cancer Institute (NCI) 37
Not applicableStudy completedNCT06953154
What this trial is testing

Monocyte Distribution Width (MDW): An Early Marker of Sepsis in Patients With Comorbidities

Who this might be right for
Sepsis
Hôpital Universitaire Sahloul 325
Next Page